Berberine vs Dihydroberberine (GlucoVantage)

Mechanism

Berberine activates AMP-activated protein kinase (AMPK), the master metabolic sensor, mimicking many effects of caloric restriction and exercise. It inhibits mitochondrial Complex I, increasing the AMP:ATP ratio which triggers AMPK. Downstream effects include enhanced GLUT4 translocation (glucose uptake), inhibition of HMG-CoA reductase (cholesterol synthesis), upregulation of LDL receptor expression, and suppression of PCSK9. It also modulates gut microbiome composition, increasing short-chain fatty acid-producing bacteria.

Standard Dosing

500mg 2-3x daily (1000-1500mg total)

Timing

With meals or immediately before meals (reduces postprandial glucose spike). Must be taken with food.

Cycle Duration

Cycle 8-12 weeks on, 4 weeks off (or continuous under practitioner supervision)

Side Effects

• GI cramping/diarrhea (dose-dependent)
• Constipation in some
• Abdominal distension
• Potential for hypoglycemia

Contraindications

• Pregnancy (uterotonic — may induce contractions)
• Lactation
• Concurrent use of multiple CYP3A4 metabolized drugs
• Severe liver disease
• Children under 12

Best Stacking Partners

Mechanism

Active metabolite of berberine with 5x greater absorption. AMPK activator that improves insulin sensitivity, reduces hepatic glucose production, and modulates gut microbiome. More bioavailable form allows lower dosing with fewer GI side effects.

Contraindications

• Same as berberine — hypoglycemia risk with diabetic medications